GA101

obinutuzumab · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GA101, covering 2017-05-05 to 2022-03-31. Get the full timeline:

Most recent: Clinical Trial Update: GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma [Phase 2]